参考文献/References:
[1]Backes D，Ｒinkel GJ，Laban KG，et al. Patient- and aneurysm-specific risk factors for intracranial aneurysm growth: a systematic review and meta-analysis．Stroke，2016,47(4):951-957.
[2]王忠诚,于春光,赵继宗,等.蛛网膜下腔出血793例临床分析.中华神经外科学杂志,1993,9(1):1-3.
[3]徐宁,王宏磊,罗祺,等.蛛网膜下腔出血506例临床分析.吉林大学学报:医学版,2004,30(1):138-140.
[4]Goksu E，Dogan O，Ulker P，et al. Pentoxifylline alleviates early brain injury in a rat model of subarachnoid hemorrhage. Acta Neurochir (Wien),2016,158(9):1721-1730.
[5]Bederson JB, Connolly JES, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: A statement for healthcare professionals from a special writing group of the stroke council American Heart Association. Stroke,2009,40(7):994-1025.
[6]马修尧，王荣，任超，等.动脉瘤性蛛网膜下腔出血后迟发性脑缺血的危险因素及预后研究.中国现代医学杂志,2017,11（26）:114-118.
[7]黄国栋,李维平,纪涛,等.显微手术治疗颅内动脉瘤322例预后影响因素分析.中国现代医学杂志,2011,21(12):1479-1482,1485.
[8]赵千山,王向宇,黄浩炜,等.出血性脑动脉瘤介入栓塞术后脑血管痉挛的临床研究.暨南大学学报,2013,34(4):413-416.
[9]鲁晓花.颅内动脉瘤破裂患者显微外科手术后脑血管痉挛的危险因素分析.山东医药,2015,55(32):40-41.
[10]Matsuoka G, Kubota Y, Okada Y. Delayed cerebral ischemia associated with reversible cerebral vasoconstriction in a patient with moyamoya disease with intraventricular hemorrhage: case report. Neuroradiol J,2015,28(3):322-324.
[11]Tseng MY, Huntchinson PJ, Czpanyka M, et al. Effects of acute avastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6m outcome in patients after aneurysma/subarachnoid hemorrhage.Stroke,2007,38(5):1545-1550.
[12]赵一平,张贺,李松柏,等.蛛网膜下腔出血痉挛常规影响诊断方法的研究.临床放射学杂志,2013,32(4):469-474.
[13]余泽,马廉亭,束枫,等.颅内动脉瘤破裂早期血管内栓塞治疗探讨.中华神经外科杂志,2005,21(2):721-723.
[14]Heros RC, Zervas NT, Varsos V. Cerevral vasospansm after subarachnoid hemorrhage: an update.Ann Neurol,1983,14(6):599-608.
[15]Fisher CM, Roverson GH, Ojemann RG. Cerebral vasospasm with ruptured saccular aneurysm:the clinical manifestations.Neurosurgery,1977,1(3):245-248.
[16]Inaqawa T, Yahara K, Ohvayashi N. Risk factors associated with cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Neurol Med Chir(Tokyo),2014,54(6):465-472.
[17]Lee YW，Nam TM，Kim JS，et al. Pure subdural hemorrhage caused by internal carotid artery dorsal wall aneurysm rupture. J Cerebrovasc Endovasc Neurosurg,2016,18(3):302-305.
[18]时雷.动脉瘤性蛛网膜下腔出血后并发脑血管痉挛的影响因素.中国实用神经疾病杂志,2016,19(19):43-45.
[19]戴永建,罗俊杰,刘岳,等.蛛网膜下腔出血致脑血管痉挛的相关影响因素研究.现代中西医结合杂志,2015,24(6):646-648.
[20]张震宇,叶新运,蒋秋华,等.重症动脉瘤性蛛网膜下腔出血后危险因素的Logistic回归分析.吉林医学,2012,33(9):1848-1849.
[21]Dsouza S. Aneurysmal subarachnoid hemorrhage.J Neurosurg Aneshesiol,2015,27(3):222-240.
[22]贾建文，刘赫，钟红亮，等.老年动脉瘤性蛛网膜下腔出血预后危险因素.中国老年学杂志,2017,10(37):5012-5013.
[23]简国庆.血管外显微手术及血管内介入栓塞治疗颅内前循环破裂动脉瘤的疗效与并发症分析.中国实用神经疾病杂志,2014,17(3):63-64.
[24]安殿梅,胡晓芳.炎性标志物在蛛网膜下腔出血后脑血管痉挛中的作用.山东医药,2012,52(9):93.
[25]王倅旭.依达拉奉联合辛伐他汀治疗颅内动脉瘤破裂术后脑血管痉挛疗效观察.山东医药,2013,53(22):69-70．
[26]买吾拉江·阿木提，麦麦提力·米吉提，培尔顿·米吉提，等.动脉瘤性蛛网膜下腔出血后脑血管痉挛的危险因素分析.中国神经精神疾病杂志,2014,40(11):682-686.
[27]李喜朋.动脉瘤性蛛网膜下腔出血后脑血管痉挛的影响因素,南方医科大学学报,2010,30(4):917-918.
[28]张翼,陈继华,夏明万,等.动脉瘤性蛛网膜下腔出血患者死亡的相关因素分析.中国当代医药,2014,21(12):34-36.
[29]Jewell RP, Saundry CM, Bonev AD, et al. Inhibition of Ca++ sparks by oxyhemoglobin in rabbit cerebral arteries. J Neurosurg,2004,100(2):295-302.
[30]杨秀娟,许宏伟,李罗清.动脉瘤性蛛网膜下腔出血后脑血管痉挛危险因素的分析.国际神经病学神经外科学杂志,2013,40(2):128-130.
[31]孙久君,何朝晖,唐玖宁,等.血红蛋白浓度与动脉瘤性蛛网膜下腔出血术后症状性脑血管痉挛的相关研究.中国神经精神疾病杂志,2014,40(5):275-278.
[32]Schneider UC, Schiffler J, Hakiy N, et a1. Functional analysis of Pro-inflammatory properties within the cerebrospinal fluid after subarachnoid hemorrhage in vivo and in vitro.Neuro inflammation,2012,2(9):28-30．
[33]Rosenberg NF, Koht A, Naidech AM. Anemia and transfusion after aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol,2013,25(1):66-74.
[34]Sen J, Beili A, Albon H, et al. Triple-H therapy in the manage.rit of aneurysmal subarachnoid hemorrhage.Lancet Neurol,2003,2(10):614-621.
[35]Muench E, Horn P, Bauhuf C, et al. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage.Crit Care Med,2007,35(8):1844-1851．
[36]Mutoh T, Ishikawa T, Suzuki A, et al. Continuous cardiac output and near-infrared spectroscopy monitoring to assist in of symptomatic cerebral vasospasm after subarachnoid hemorrhage. Neurocrit Care,2010,13(3):331-338．
[37]徐跃峤,王宁,胡锦,等.重症动脉瘤性蛛网膜下腔出血管理专家共识（2015）.中国脑血管病杂志,2015,12(4):215-224.
[38]Pierot L, Affour M, Moret J. Vasospasm after aneurysmal subarachnoid hemorrhage: Recent advances in endovascular management. Curr Opin Crit Care,2010,16(2):110-116.
[39]斯良楠,孙晓川,张晓冬.经动脉灌注尼莫地平治疗蛛网膜下腔出血后脑血管痉挛.中国介入影响与治疗学,2015,12(9):527-531.
[40]Kirkpatrick PJ, Turner CL, Smith C, et al. Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicenter randomised phase 3 trial.Lancet Neurol,2014,13(7):666-675.
[41]Dhar R, Diringer M. Statins and anti-inflammatory therapies for subarachnoid hemorrhage.Curr Treat Options Neurol,2012,14(2):164-174.
[42]Tseng MY, Czosnyka M, Richards H, et al. Effects of acute treatment with pravastatin on cerebral vasospasm autoregulation and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage.Stroke,2005,36(8):1627-1632.
[43]刘勇,王淳,易兴阳,等.阿托伐他汀钙对动脉瘤性蛛网膜下腔出血后脑血管痉挛的作用及机制.国际神经病学神经外科学杂志,2016,43(4):297-301.
[44]Lynch JR, Wang H, McGirt MJ, et al. Simvastatin reduces vasospasm after aneurysmal suvarachnoid hemorrhage, results of a pilot randomized clinical trial. Stroke,2005,36(8):2024-2026.
[45]Lad SP, Heqen H, Gupta G, et al. Proteomic bilmarker discovery in cerebrospinal fluid for cerevral vasospasm following suvarachnoid hemorrhage. J Stroke Cerebrovasc Dis,2012,1(21):30-41.
[46]Han J，Lim DJ，Kim SD，et al. Subdural hematoma without subarachnoid hemorrhage caused by the rupture of middle cerebral artery aneurysm．J Cerebrovasc Endovasc Neurosurg,2016,18(3):315-321.
[47]Santiago-Sim T，Fang X，Hennessy ML, et al. THSD1(thrombospondin type 1 domain containing protein 1) mutation in the pathogenesis of intracranial aneurysm and subarachnoid hemorrhage．Stroke,2016,47(12) :3005-3013.
[48]Kasuya H, Shimizu T, Kagawa M. The effect of continuous drainage of cerebrospinal fluid in patients with subarachnoid hemorrhage:a retrospective analysis of 108 patients.Neurosurgery,1991,28(1):56-59.
[49]Fulop B, Deak G, Mencser Z, et al. Factors attecting the development of chronic hydrocephalus following subarachnoid hemorrhage, with special emphasisi on the role of ventricular and lumbar drainage. Ideggyogy Sz,2009,62(7-8):255-261(in Hungarian).
[50]邵军,陈高,胡华,等.动脉瘤性蛛网膜下腔出血患者腰大池引流减少脑积水发生影响因素分析.浙江大学学报（医学版）,2014,43(1):71-76.
[51]韩金涛,傅军,李选,等.动脉瘤性蛛网膜下腔出血栓塞术后早期连续腰椎穿刺治疗的疗效.北京大学学报（医学版）,2013,45(4):639-642.
[52]傅军,李选,韩金涛,等.颅内动脉瘤介入治疗围手术期处理的研究.中国微创外科杂志,2015,15（2）：97-100.